Autoimmune Disease Diagnostics Market: Industry Analysis, Trend, Growth, Opportunity, Forecast 2022-2030
Autoimmune Disease Diagnostics Market report gives attention to market segmentation, market size, and forecast of 2022-2030 to help stakeholders in making a good decision for the future investments. Bioreactors industry report segmented into types, application, and regions with providing production, revenue, import/export.
Recently, a December 2021 study published in Cells analyzed the dysregulation of the immune system caused by the COVID-19 infection, which could lead to the development of autoimmune phenomena. The research findings indicated that the coronavirus infection could precipitate systemic and rheumatic autoimmune diseases, establishing a link between the illness and new onset-rheumatic diseases to promote early diagnosis and timely therapeutic management.
Browse key industry insights spread across 190 pages with 292 market data tables & 17 figures & charts from the report, “Autoimmune Disease Diagnostics Market Analysis By Disease Type (Systemic Autoimmune Disease {Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Psoriasis, Multiple Sclerosis}, Localized Autoimmune Disease {Inflammatory Bowel Disease, Type 1 Diabetes, Thyroid), Test Type (Antinuclear Antibody Tests, Autoantibody Tests, C-reactive Protein (CRP), Complete Blood Count (CBC), Urinalysis), End-use (Hospitals, Diagnostic Centers), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/autoimmune-disease-diagnostics-market
Thus, the burgeoning need for diagnosing autoimmune diseases has fueled autoimmune disease diagnostics market growth considerably. Moreover, rapid advancements in autoimmune disease diagnostic systems have also stimulated business growth in the past few years.
Major companies have been focusing on strategic partnerships, mergers, collaborations, and product innovation to maintain a strong presence in the market, fostering the competitive outlook of the industry. For instance, in March 2021, Bio-Rad Laboratories, a medical device company, extended its agreement with diagnostics behemoth Roche by offering its InteliQ product range. This deal aimed to fortify the partnership between the two firms.
The autoimmune disease diagnostics market has been bifurcated in terms of end-use, test type, disease type, and region.
By disease type, the autoimmune disease diagnostics industry has been split into localized autoimmune disease and systemic autoimmune disease. The systemic autoimmune disease segment was valued at more than $327 million in 2021 attributed to the growing influence of rheumatoid arthritis, systemic lupus erythematosus (SLE), psoriasis, and so on, which has increased the need for diagnosis of these conditions.
The autoimmune disease diagnostics market has been categorized on the basis of test type into urinalysis, antinuclear antibody tests, complete blood count (CBC), autoantibody tests, c-reactive protein (CRP), and others. In 2021, the antinuclear antibody tests segment accounted for a revenue share of around 43% as a result of rising incidences of chronic ailments and diseases that target the immune systems such as type 1 diabetes, myasthenia gravis, and others.
With regards to end-use, the autoimmune disease diagnostics industry has been divided into diagnostics centers, hospitals, and others. The hospitals segment attained a valuation of over $591 million in 2021 on account of viable medical policies and surging availability of modern autoimmune diagnostics technologies that promote patient satisfaction and convenience.
Partial Table of Contents (ToC) of the report:
Chapter 4 Autoimmune Disease Diagnostics Market, By Disease Type
4.1 Key segment trends
4.2 Systemic Autoimmune Disease
4.2.1 Market size, by region, 2017 - 2030 (USD Million)
4.2.2 Rheumatoid Arthritis
4.2.2.1 Market size, by region, 2017 - 2030 (USD Million)
4.2.3 Systemic Lupus Erythematosus
4.2.3.1 Market size, by region, 2017 - 2030 (USD Million)
4.2.4 Psoriasis
4.2.4.1 Market size, by region, 2017 - 2030 (USD Million)
4.2.5 Multiple Sclerosis
4.2.5.1 Market size, by region, 2017 - 2030 (USD Million)
4.2.6 Others
4.2.6.1 Market size, by region, 2017 - 2030 (USD Million)
4.3 Localized Autoimmune Disease
4.3.1 Market size, by region, 2017 - 2030 (USD Million)
4.3.2 Inflammatory Bowel Disease
4.3.2.1 Market size, by region, 2017 - 2030 (USD Million)
4.3.2.2 Type 1 Diabetes
4.3.2.2.1 Market size, by region, 2017 - 2030 (USD Million)
4.3.2.3 Thyroid
4.3.2.3.1 Market size, by region, 2017 - 2030 (USD Million)
4.3.2.4 Others
4.3.2.4.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 5 Autoimmune Disease Diagnostics Market, By Test Type
5.1 Key segment trends
5.2 Antinuclear Antibody Tests
5.2.1 Market size, by region, 2017 - 2030 (USD Million)
5.3 Autoantibody Tests
5.3.1 Market size, by region, 2017 - 2030 (USD Million)
5.4 C-reactive Protein (CRP)
5.4.1 Market size, by region, 2017 - 2030 (USD Million)
5.5 Complete Blood Count (CBC)
5.5.1 Market size, by region, 2017 - 2030 (USD Million)
5.6 Urinalysis
5.6.1 Market size, by region, 2017 - 2030 (USD Million)
5.7 Others
5.7.1 Market size, by region, 2017 - 2030 (USD Million)
Browse complete table of content of this report @ https://www.gminsights.com/toc/detail/autoimmune-disease-diagnostics-market
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us
Aashit Tiwari
Corporate Sales, USA
Global Market Insights Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: [email protected]